
Chris Rinsch
Chris Rinsch is a Swiss entrepreneur and co-founder of the biotechnology startup Amazentis, known for its work on Urolithin A, a compound that promotes mitochondrial health and has potential anti-aging benefits. He is a former doctoral student at the École Polytechnique Fédérale de Lausanne (EPFL) and has been instrumental in bringing scientific innovations from the lab to the consumer market.
Power624
Reach7,714
Country presence
Recent news mentions
Chris Rinsch co-founded the startup Amazentis with Patrick Aebischer in 2007.
Longevity-Firma Timeline soll Einhorn werdenNeue Zürcher Zeitung·
Switzerland· 2026-07-27







